Literature DB >> 29859010

Apolipoprotein E favours the blunting by high-fat diet of prostacyclin receptor activation in the mouse aorta.

Yanhua Cheng1, Paul M Vanhoutte1, Susan W S Leung1.   

Abstract

BACKGROUND AND
PURPOSE: NO-mediated, endothelium-dependent relaxations of isolated arteries are blunted by ageing and high-fat diets, as well as by apolipoprotein E deletion. The present study was designed to test the hypothesis that apolipoprotein E deletion impairs endothelium-dependent responses to prostacyclin (IP) receptor activation. EXPERIMENTAL APPROACH: Five-week-old ApoE+/+ and ApoE-/- mice were fed normal chow or high-fat diet for 29 weeks. The aortae were isolated for the measurements of isometric tension in Halpern-Mulvany myographs. Levels of proteins were assessed by Western blotting and immunofluorescence, and cyclic nucleotide levels by elisa. KEY
RESULTS: The IP receptor agonist, iloprost, induced endothelium-, NO-synthase- and IP-dependent relaxations in aortae of young ApoE+/+ mice. High-fat diet favoured activation of thromboxane receptors by iloprost, causing contraction. Apolipoprotein E was present in aortae of ApoE+/+ mice, especially in endothelium. Its presence was augmented by high-fat diet. Its deletion potentiated iloprost-induced relaxations in aortae of young mice and prevented the blunting of this response by high-fat diet. Levels of cAMP were higher, but those of cGMP were lower in the aorta of ApoE-/- than in ApoE+/+ mice of the same age. The levels of IP receptor protein were not different between ApoE+/+ and ApoE-/- mice. CONCLUSIONS AND IMPLICATIONS: Iloprost induced an endothelium-dependent relaxation in the aorta of young healthy mice which involved both the cGMP and cAMP pathways. This response was blunted by prolonged exposure to a high-fat diet. Apolipoprotein E deletion potentiated relaxations to IP receptor activation, independently of age and diet.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29859010      PMCID: PMC6086984          DOI: 10.1111/bph.14386

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

Authors:  John C McGrath; Elliot Lilley
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

2.  New insights into structural determinants for prostanoid thromboxane A2 receptor- and prostacyclin receptor-G protein coupling.

Authors:  Raja Chakraborty; Sai Prasad Pydi; Scott Gleim; Rajinder Pal Bhullar; John Hwa; Shyamala Dakshinamurti; Prashen Chelikani
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

Review 3.  Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies.

Authors:  M F Linton; S Fazio
Journal:  Curr Opin Lipidol       Date:  1999-04       Impact factor: 4.776

4.  Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.

Authors:  D R Riddell; A Graham; J S Owen
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

Review 5.  A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.

Authors:  Raymond Coleman; Tony Hayek; Shlomo Keidar; Michael Aviram
Journal:  Acta Histochem       Date:  2006-09-26       Impact factor: 2.479

Review 6.  Nitric oxide: orchestrator of endothelium-dependent responses.

Authors:  Michel Félétou; Ralf Köhler; Paul M Vanhoutte
Journal:  Ann Med       Date:  2011-09-07       Impact factor: 4.709

Review 7.  Prostanoids in health and disease.

Authors:  Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2008-12-17       Impact factor: 5.922

Review 8.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

9.  Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.

Authors:  G S Baxter; J K Clayton; R A Coleman; K Marshall; R Sangha; J Senior
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Prostacyclin.

Authors:  J R Vane
Journal:  J R Soc Med       Date:  1983-04       Impact factor: 18.000

View more
  1 in total

1.  EP3 Blockade Adds to the Effect of TP Deficiency in Alleviating Endothelial Dysfunction in Atherosclerotic Mouse Aortas.

Authors:  Chuangjia Hu; Bin Liu; Yineng Xu; Xiangzhong Wu; Tingting Guo; Yingzhan Zhang; Jing Leng; Jiahui Ge; Gang Yu; Jinwei Guo; Yingbi Zhou
Journal:  Front Physiol       Date:  2019-09-26       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.